Drug Profile
Progesterone transdermal - Dimera
Alternative Names: DP 9Latest Information Update: 25 Dec 2021
Price :
$50
*
At a glance
- Originator Dimera
- Class Cardiovascular therapies; Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Myocardial ischaemia
Highest Development Phases
- No development reported Myocardial ischaemia
Most Recent Events
- 11 Oct 2018 No recent reports on development identified - phase II for Myocardial ischaemia (Prevention, Prevention of relapse) in USA (Transdermal)
- 30 Nov 2015 Progesterone transdermal - Dimera is available for licensing (ww.dimera.net)
- 27 Nov 2015 Phase-II clinical trials in Myocardial ischaemia (Prevention of relapse, Prevention) in USA (Transdermal)